Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This news virtually guarantees FDA approval.
GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market
https://finance.yahoo.com/news/gen-commercialize-jaguar-healths-crofelemer-123000590.html
WOW! .108 kabooooooooooooom
HIGHLIGHT JUVENTIX POTENTIAL REVENUE...
The bashers know there is huge money to be made here. If they are aligned with the short sellers, they understand that once everything is finalized—shares exchanged and the name, and symbol changed —the short sellers and naked shorts will be compelled to cover, irrespective of their intentions.
Here is my calculation after the share exchanged. KOAN o/s increasing up to 118,889,223 that is. No debt and no note or toxic conversion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174062329
To address the question, I mentioned to the board, that the name of the company is JUVENTIX has 400 more reps joining, which should effectively double the revenue from the current 4.5 million to 10 million or more.
Specifically, 700 sales reps are selling JUVENTIX products. JUVENTIX is one of the subsidiaries of APOLLO BioWellness. They manufacture their products under their brand and distribute them to doctors and hospitals throughout the USA, possibly expanding globally soon. Under Morrison's management, I foresee JUVENTIX potentially generating over a hundred million per year within a 3 to 5-year timeframe. And this is just one of the subsidiaries of APOLLO BioWellness. With that in mind, this stock has the potential to move to Dollar Land doable.
Serious investors should take the time to thoroughly examine what they offer here. JUVENTIX owns Juventix PRP™, an FDA-cleared 510(k) Class II Medical Device. Additionally, products like DermaMend light therapy laser and PhysioPro Shockwave therapy sell for ten thousand dollars each.
Over 40 years of research on the stocks. I've never seen an opportunity to acquire a real company with an FDA-cleared 510(k) Class II Medical Device for such a low price, well under one cent. People need to wake up and hold tight to their investments because opportunities like this come around once in a lifetime. You can mark this post.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=629835&lpcd=ORG
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174069986
YES! NO R/S. There's no point in arguing with him. Despite being aware of his inaccuracies, he persists REHASHED ENDLESS false claims about the reverse split. He reminds me of the dirty PIG no matter how you FEED them they always go back to the same shithole. Lmao:))
The company has made significant announcements, including a change in its name back to Apollo and the adoption of a reverse split amendment on 08/03/2023, to be effective no later than September 30, 2023. Since the reverse split did not take effect by September 30, 2023, it is required by law to be filed with the Wyoming Secretary of State, which has been done. The change in the company's name back to Apollo was also filed with the Secretary of State on 09/01/2023, both on the same day.
12/06/2023 The name was changed from Apollo Biwellness to Emergent, then 09/01/2023 reverted from Emergent, to Apollo indicating Apollo terminated the R/S reverse merger with EMGE.
One day after Sep 30, 2023
There's no reverse split—it's clearly stated. Filed: 09/01/2023.
Please read my post below. I have explained it very clearly and even posted the filings for him to see, but he refuses to acknowledge it.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174057400
I love the cheapies. I just bought 475,000 shares locked up to my piles for penny land.
03/19/24 03:54 PM ET Buy 450000 EMGE Executed @ $0.0019
03/19/24 03:54 PM ET Buy 25000 EMGE Executed @ $0.001875
$ EMGE - INTEGRATIVE PRACTICE SOLUTION
Integrative Practice Solutions, LLC is an innovative clinical business model that focuses on resolving Osteoarthritic knee pain experienced by over 27 million elderly Americans. Their approach, known as the Advanced Arthritis Relief Protocol™ (AARP), offers a non-surgical solution for treating knee pain caused by Osteoarthritis. This comprehensive program combines non-surgical intra-articular hyaluronic acid injections, specialized knee bracing, and a comprehensive physical therapy program.
"With over 230 highly successful integrated clients in 46 states and growing, the AARP program is producing multi-million-dollar earners throughout the United States"
$EMGE - EVOLUTIONARY BIOLOGICSIS
Evolutionary Biologicsis is among the subsidiaries of APOLLO BioWellness. Explore their impressive website linked below and take a look at their product line as well.
https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing these products with a well-thought-out game plan. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
JUVENTIX is one of the subsidiaries of APOLLO BioWellness.
https://shop.juventix.com/
We owned Juventix PRP™, an FDA-cleared 510(k) Class II Medical Device.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=629835&lpcd=ORG
In addition to the medical equipment mentioned above, they also have an extensive range of medical products.
https://shop.juventix.com/collections/juventix-product-line
BULLISH
When the pump bashers endlessly repeat FAKE the reverse split NONESENCE, their aim is to brainwash and manipulate you into selling. There's absolutely no way they would execute a reverse split because at the current price per share (PPS) of .0022, that would value the PPS at $11. The bashers want you to buy into the absurd notion that the KOAN .048 exchange equals $11 per share. If you fall for this ridiculous manipulation, then the outcome is clear you deserve to get your ass kicked hard. Rotflmao.
Still confused? Please read the detailed explanation provided in the sticky above.
Appreciate your info.
$ EMGE - INTEGRATIVE PRACTICE SOLUTION
Integrative Practice Solutions, LLC is an innovative clinical business model that focuses on resolving Osteoarthritic knee pain experienced by over 27 million elderly Americans. Their approach, known as the Advanced Arthritis Relief Protocol™ (AARP), offers a non-surgical solution for treating knee pain caused by Osteoarthritis. This comprehensive program combines non-surgical intra-articular hyaluronic acid injections, specialized knee bracing, and a comprehensive physical therapy program.
"With over 230 highly successful integrated clients in 46 states and growing, the AARP program is producing multi-million-dollar earners throughout the United States"
$ EMGE - INTEGRATIVE PRACTICE SOLUTION
Integrative Practice Solutions, LLC is an innovative clinical business model that focuses on resolving Osteoarthritic knee pain experienced by over 27 million elderly Americans. Their approach, known as the Advanced Arthritis Relief Protocol™ (AARP), offers a non-surgical solution for treating knee pain caused by Osteoarthritis. This comprehensive program combines non-surgical intra-articular hyaluronic acid injections, specialized knee bracing, and a comprehensive physical therapy program.
"With over 230 highly successful integrated clients in 46 states and growing, the AARP program is producing multi-million-dollar earners throughout the United States"
$EMGE - EVOLUTIONARY BIOLOGICSIS
Evolutionary Biologicsis is among the subsidiaries of APOLLO BioWellness. Explore their impressive website linked below and take a look at their product line as well.
https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing these products with a well-thought-out game plan. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE - EVOLUTIONARY BIOLOGICSIS
Evolutionary Biologicsis is among the subsidiaries of APOLLO BioWellness. Explore their impressive website linked below and take a look at their product line as well.
https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing these products with a well-thought-out game plan. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE This stock is still flying under the radar, as many have yet to fully comprehend the potential impact of its completed merger. However, it's only a matter of time before the true potential of this opportunity is realized. This merger is a significant game-changer. One advantageous aspect is that all preferred shares are locked up for one year, alleviating concerns about insider conversion to common shares and dilution. Additionally, Mr. Jim Morrison has assumed the role of Chairman and CEO of Apollo Biowellness. Mr. Morrison is a legend in the personal care industry, most notably as President of L'Oréal for 9 years. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. He is considered one of the top brand strategists in the personal care space. I believe his leadership is poised to steer the company toward success and simultaneously reward stakeholders.
APOLLO BioWellness's subsidiaries:
https://evolutionarybiologics.com/
https://integrativepracticesolutions.com/
https://apollobiowellness.com/wholistic/
https://juventix.com/
https://apollobiowellness.com/maximus/
$EMGE This stock is still flying under the radar, as many have yet to fully comprehend the potential impact of its completed merger. However, it's only a matter of time before the true potential of this opportunity is realized. This merger is a significant game-changer. One advantageous aspect is that all preferred shares are locked up for one year, alleviating concerns about insider conversion to common shares and dilution. Additionally, Mr. Jim Morrison has assumed the role of Chairman and CEO of Apollo Biowellness. Mr. Morrison is a legend in the personal care industry, most notably as President of L'Oréal for 9 years. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. He is considered one of the top brand strategists in the personal care space. I believe his leadership is poised to steer the company toward success and simultaneously reward stakeholders.
APOLLO BioWellness's subsidiaries:
https://evolutionarybiologics.com/
https://integrativepracticesolutions.com/
https://apollobiowellness.com/wholistic/
https://juventix.com/
https://apollobiowellness.com/maximus/
$EMGE YUP! We owned Juventix PRP™, an FDA-cleared 510(k) Class II Medical Device.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=629835&lpcd=ORG
JUVENTIX is one of the subsidiaries of APOLLO BioWellness.
https://shop.juventix.com/
In addition to the medical equipment mentioned above, they also have an extensive range of medical products.
https://shop.juventix.com/collections/juventix-product-line
BULLISH
$EMGE YUP! We owned Juventix PRP™, an FDA-cleared 510(k) Class II Medical Device.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=629835&lpcd=ORG
JUVENTIX is one of the subsidiaries of APOLLO BioWellness.
https://shop.juventix.com/
In addition to the medical equipment mentioned above, they also have an extensive range of medical products.
https://shop.juventix.com/collections/juventix-product-line
BULLISH
I completely agree with your perspective. That's why I'm still holding a portion for the journey ahead.
NO R/S! STOP BEING IGNORANT AND PRETENDING NOTHING HAS CHANGED.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174057400
YUP! We owned Juventix PRP™, an FDA-cleared 510(k) Class II Medical Device.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=629835&lpcd=ORG
JUVENTIX is one of the subsidiaries of APOLLO BioWellness.
https://shop.juventix.com/
In addition to the medical equipment mentioned above, they also have an extensive range of medical products.
https://shop.juventix.com/collections/juventix-product-line
WHICH ONE OF THEIR SUBSIDIARIES BOASTS A WHOPPING 700+ SALES REPS?
I am thrilled to see someone here actually talk about the companies. If more people are focusing on the fundamentals, then we can regain our ground and continue to move higher. Yes, social media can blow things up quickly. On top of that Morrison has the Cinema ads campaign ready for marketing a high-end biologic product with a well-thought-out game plan.
Emergent Health will become THE WHOLISTIC COMPANY operations of Wholistic Brands.
Below is just an example of the new line of products being developed by "The Wholistic Company".
The estimate of .08 is only for one subsidiary. We have five subsidiaries.
Last week, I acquired 850k shares, some as high as .0036. In my humble opinion, anything under one cent is a gift. According to their statement, one subsidiary project generated revenue of 9 million. Now, we need to calculate the value of the company's price per share based on the performance of just one of their five subsidiaries after the common share exchange.
KOAN common share .047
EMGE common share .0025
Assume the common shares exchange at the current rate that is 1 to 18.8 the math .047devides .0025 = 18.8
EMGE total o/s 426,951,112 divides by 18.8 = 22,710,165 new shares
After the exchange, KOAN o/s increasing 22,710,165
KOAN current o/s 96,179,058 + 22,710,165 = 118,889,223
revenue $9m / 118,889,223 = 8 cent per share.
Let's have some fun with this challenge! I'm calling on all you savvy individuals out there to figure out which one of their subsidiaries boasts a whopping 700 sales reps. Who's up for the challenge? Lol:)))
EXCITING NEWS! HAVE YOU ALL NOTICED THE RECENT CHANGE REPORT ON THE NEWS?
OMG, Am I the only one who noticed the change here? I've stumbled upon some remarkable discoveries, FULL UPDATE DD I posted yesterday, and I'm surprised only one person has READ and made commented on them. LMAO:))
Look like they are on target to double the 5.4 million revenues. That is just one subsidiary. According to recent NEWS reports,
Yes, great bargain price level. I went to the store and bought some food. Just check my buy order they gave me 165,000 shares.
03/18/24 11:14 AM ET Buy 165000 EMGE Executed @ $0.0024
I just did. Thank God now I don't have to deal with that stupid dumbass.
I have to put you on ignore; I can't fix stupid. You're like a dog with a chew toy that won't let it go... you are preaching to the choir over here and won't stop... I get it, everyone gets it, we know a $0.0025 stock is almost guaranteed to be a diluted POS with an R/S on deck... whatever the reason, you keep repeating and barking the same fake bullshit and won't let it go. Go find yourself a new toy to play with. You are embarrassing yourself here. Let it go, man!
STOP BEING IGNORANT AND PRETENDING NOTHING HAS CHANGED.
If the reverse split is legitimate, it should be addressed within SECTION 1.01 to SECTION 8.15, not buried at the bottom of the page. Your continued rehash of postings same craps only serves to highlight your stupid lack of understanding. Unfortunately, you cannot comprehend the layout of legal documents.
Within the share exchange agreement, it's crucial to pay attention to each Section. If any section is skipped, the entire agreement becomes void. From Section 1.01 to the end of section 8.15 on page 25 is signed by all parties, marking the end of the Definitive Agreement. Comprehend?
Now, take note of page 26, where you claim the reverse split occurred. Pay attention to the word (Schedule) why do they state schedule and not Section? Because that is not part of the Definitive Agreement. It is like purchasing the car and by law, they must disclose the accident damage to the car. If the R/S is still pending, then they must report in the SECTION part.
I'll keep posting knowledge in the face of ignorance.
Let's clarify again: the previous reverse split was for the old pending reverse merger between EMGE and Apollo, which fell through. In September 2023, the name was changed from Emergent to Apollo, then reverted to Emergent, indicating Apollo backed out. This is a factual matter. Note the filing date, the same as the filing to cancel the reverse split. If the board approves the reverse split, it would have been done in Sept 2023. Decisions on R/S approval are made by the board of directors, not FINRA.
FINRA does not approve reverse splits, but it does process reverse stock splits as part of its functions related to company corporate actions in the OTC market.
Furthermore, it's been nearly 8 months since then. Let's not deceive ourselves; no company waits that long to carry out a reverse split.
https://www.finra.org/investors/investing/investment-products/stocks/stock-splits
It makes no sense for a common share exchange with KOAN when it's trading around 3 cents. With EMGE at .003 and a reverse split, it would reach $15.00 per share, which doesn't align. Furthermore, it's unbelievable to consider a 1/5000 split with these outstanding shares. If such a split occurred, the entire float would be only 58,540 shares. It's UNBELIEVABLE that some idiot still fails to comprehend this.
Don't even think of swaying fake lies claiming the shares are convertible into around a billion shares of common stock. Morrison holds a significant percentage of preferred shares. After the exchange, all EMGE preferred shares are converted back into KOAN preferred stock and locked up for a year, as mandated by the SEC. If anyone takes your claims seriously, they do so at their own risk.
I appreciate your kind words, my friend.
$EMGE CRUCIAL INSIGHT: Recognizing the Significance of Learning the Truth...
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger was executed. KOAN and EMGE common shares will maintain their regular trading activity until the 251(g) of the new company is finalized. What makes this merger exceptional is the absence of previous reverse splits, the elimination of debts, and no further dilution. On top of that, the float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is exceedingly rare in the realm of OTC land.
Most of us including me have a hard time comprehending the triangular merger agreement. The key question we need to address is the fate of the EMGE common shareholders. The agreement indicates that KOAN will obtain all of the EMGE Equity Interests from the EMGE Preferred Shareholders. While it doesn't directly specify common shares, the term "EMGE Equity Interests" generally covers all forms of equity ownership in EMGE, encompassing both preferred and common shares. Below are the relevant sections from the agreement:
$EMGE CRUCIAL INSIGHT: Recognizing the Significance of Learning the Truth...
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger was executed. KOAN and EMGE common shares will maintain their regular trading activity until the 251(g) of the new company is finalized. What makes this merger exceptional is the absence of previous reverse splits, the elimination of debts, and no further dilution. On top of that, the float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is exceedingly rare in the realm of OTC land.
Most of us including me have a hard time comprehending the triangular merger agreement. The key question we need to address is the fate of the EMGE common shareholders. The agreement indicates that KOAN will obtain all of the EMGE Equity Interests from the EMGE Preferred Shareholders. While it doesn't directly specify common shares, the term "EMGE Equity Interests" generally covers all forms of equity ownership in EMGE, encompassing both preferred and common shares. Below are the relevant sections from the agreement:
$EMGE CRUCIAL INSIGHT: Recognizing the Significance of Learning the Truth...
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger was executed. KOAN and EMGE common shares will maintain their regular trading activity until the 251(g) of the new company is finalized. What makes this merger exceptional is the absence of previous reverse splits, the elimination of debts, and no further dilution. On top of that, the float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is exceedingly rare in the realm of OTC land.
Most of us including me have a hard time comprehending the triangular merger agreement. The key question we need to address is the fate of the EMGE common shareholders. The agreement indicates that KOAN will obtain all of the EMGE Equity Interests from the EMGE Preferred Shareholders. While it doesn't directly specify common shares, the term "EMGE Equity Interests" generally covers all forms of equity ownership in EMGE, encompassing both preferred and common shares. Below are the relevant sections from the agreement:
It's astonishing how some people react to news in the market these days. It's the usual behavior of Ihub grasshoppers, but that's fine. People come and go constantly. I anticipate that only a select few individuals with a clear vision, capable of seeing the bigger picture, will remain here in the end.
The company released some incredible news. It seems to be more of an update, packed with highly valuable information, and some individuals didn't grasp it on their initial read-through. Honestly, I had to read it a few times to fully understand the important messages they aim to convey. The quote below is particularly challenging to digest due to its abundance of details condensed into a very brief sentence.